Cargando…
Scalable Access to Arylomycins via C–H Functionalization Logic
[Image: see text] Arylomycins are a promising class of “latent” antibacterial natural products currently in preclinical development. Access to analogues within this family has previously required a lengthy route involving multiple functional group manipulations that is costly and time-intensive on s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817625/ https://www.ncbi.nlm.nih.gov/pubmed/29381350 http://dx.doi.org/10.1021/jacs.8b00087 |
_version_ | 1783300897592311808 |
---|---|
author | Peters, David S. Romesberg, Floyd E. Baran, Phil S. |
author_facet | Peters, David S. Romesberg, Floyd E. Baran, Phil S. |
author_sort | Peters, David S. |
collection | PubMed |
description | [Image: see text] Arylomycins are a promising class of “latent” antibacterial natural products currently in preclinical development. Access to analogues within this family has previously required a lengthy route involving multiple functional group manipulations that is costly and time-intensive on scale. This study presents a simplified route predicated on simple C–H functionalization logic that is enabled by a Cu-mediated oxidative phenol coupling that mimics the putative biosynthesis. This operationally simple macrocyclization is the largest of its kind and can be easily performed on gram scale. The application of this new route to a formal synthesis of the natural product and a collection of new analogues along with their biological evaluation is also reported. |
format | Online Article Text |
id | pubmed-5817625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-58176252018-02-20 Scalable Access to Arylomycins via C–H Functionalization Logic Peters, David S. Romesberg, Floyd E. Baran, Phil S. J Am Chem Soc [Image: see text] Arylomycins are a promising class of “latent” antibacterial natural products currently in preclinical development. Access to analogues within this family has previously required a lengthy route involving multiple functional group manipulations that is costly and time-intensive on scale. This study presents a simplified route predicated on simple C–H functionalization logic that is enabled by a Cu-mediated oxidative phenol coupling that mimics the putative biosynthesis. This operationally simple macrocyclization is the largest of its kind and can be easily performed on gram scale. The application of this new route to a formal synthesis of the natural product and a collection of new analogues along with their biological evaluation is also reported. American Chemical Society 2018-01-30 2018-02-14 /pmc/articles/PMC5817625/ /pubmed/29381350 http://dx.doi.org/10.1021/jacs.8b00087 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Peters, David S. Romesberg, Floyd E. Baran, Phil S. Scalable Access to Arylomycins via C–H Functionalization Logic |
title | Scalable
Access to Arylomycins via C–H Functionalization
Logic |
title_full | Scalable
Access to Arylomycins via C–H Functionalization
Logic |
title_fullStr | Scalable
Access to Arylomycins via C–H Functionalization
Logic |
title_full_unstemmed | Scalable
Access to Arylomycins via C–H Functionalization
Logic |
title_short | Scalable
Access to Arylomycins via C–H Functionalization
Logic |
title_sort | scalable
access to arylomycins via c–h functionalization
logic |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817625/ https://www.ncbi.nlm.nih.gov/pubmed/29381350 http://dx.doi.org/10.1021/jacs.8b00087 |
work_keys_str_mv | AT petersdavids scalableaccesstoarylomycinsviachfunctionalizationlogic AT romesbergfloyde scalableaccesstoarylomycinsviachfunctionalizationlogic AT baranphils scalableaccesstoarylomycinsviachfunctionalizationlogic |